nodes	percent_of_prediction	percent_of_DWPC	metapath
Levocabastine—HRH1—atherosclerosis	0.855	1	CbGaD
Levocabastine—Pharyngitis—Rosuvastatin—atherosclerosis	0.00108	0.0339	CcSEcCtD
Levocabastine—Pharyngitis—Ezetimibe—atherosclerosis	0.000898	0.0282	CcSEcCtD
Levocabastine—Cough—Rosuvastatin—atherosclerosis	0.000827	0.026	CcSEcCtD
Levocabastine—Erythema—Ezetimibe—atherosclerosis	0.000788	0.0247	CcSEcCtD
Levocabastine—Pharyngitis—Pravastatin—atherosclerosis	0.000774	0.0243	CcSEcCtD
Levocabastine—Visual impairment—Niacin—atherosclerosis	0.000763	0.024	CcSEcCtD
Levocabastine—Visual impairment—Pravastatin—atherosclerosis	0.000752	0.0236	CcSEcCtD
Levocabastine—Erythema—Simvastatin—atherosclerosis	0.000751	0.0236	CcSEcCtD
Levocabastine—Erythema—Niacin—atherosclerosis	0.00069	0.0217	CcSEcCtD
Levocabastine—Cough—Ezetimibe—atherosclerosis	0.000687	0.0216	CcSEcCtD
Levocabastine—Dry mouth—Lovastatin—atherosclerosis	0.000669	0.021	CcSEcCtD
Levocabastine—Pain—Rosuvastatin—atherosclerosis	0.000661	0.0208	CcSEcCtD
Levocabastine—Dry mouth—Ezetimibe—atherosclerosis	0.000656	0.0206	CcSEcCtD
Levocabastine—Cough—Niacin—atherosclerosis	0.000602	0.0189	CcSEcCtD
Levocabastine—Cough—Pravastatin—atherosclerosis	0.000593	0.0186	CcSEcCtD
Levocabastine—Dyspnoea—Lovastatin—atherosclerosis	0.000584	0.0183	CcSEcCtD
Levocabastine—Dry mouth—Niacin—atherosclerosis	0.000574	0.018	CcSEcCtD
Levocabastine—Dyspnoea—Ezetimibe—atherosclerosis	0.000573	0.018	CcSEcCtD
Levocabastine—Fatigue—Lovastatin—atherosclerosis	0.000565	0.0177	CcSEcCtD
Levocabastine—Pain—Lovastatin—atherosclerosis	0.00056	0.0176	CcSEcCtD
Levocabastine—Asthenia—Rosuvastatin—atherosclerosis	0.000555	0.0174	CcSEcCtD
Levocabastine—Fatigue—Ezetimibe—atherosclerosis	0.000554	0.0174	CcSEcCtD
Levocabastine—Pain—Ezetimibe—atherosclerosis	0.00055	0.0173	CcSEcCtD
Levocabastine—Dyspnoea—Simvastatin—atherosclerosis	0.000546	0.0172	CcSEcCtD
Levocabastine—Fatigue—Simvastatin—atherosclerosis	0.000528	0.0166	CcSEcCtD
Levocabastine—Pain—Simvastatin—atherosclerosis	0.000524	0.0165	CcSEcCtD
Levocabastine—Dyspnoea—Niacin—atherosclerosis	0.000502	0.0158	CcSEcCtD
Levocabastine—Somnolence—Niacin—atherosclerosis	0.0005	0.0157	CcSEcCtD
Levocabastine—Dyspnoea—Pravastatin—atherosclerosis	0.000494	0.0155	CcSEcCtD
Levocabastine—Rash—Rosuvastatin—atherosclerosis	0.000488	0.0153	CcSEcCtD
Levocabastine—Dermatitis—Rosuvastatin—atherosclerosis	0.000487	0.0153	CcSEcCtD
Levocabastine—Headache—Rosuvastatin—atherosclerosis	0.000484	0.0152	CcSEcCtD
Levocabastine—Pain—Niacin—atherosclerosis	0.000481	0.0151	CcSEcCtD
Levocabastine—Fatigue—Pravastatin—atherosclerosis	0.000478	0.015	CcSEcCtD
Levocabastine—Pain—Pravastatin—atherosclerosis	0.000474	0.0149	CcSEcCtD
Levocabastine—Asthenia—Lovastatin—atherosclerosis	0.00047	0.0148	CcSEcCtD
Levocabastine—Asthenia—Ezetimibe—atherosclerosis	0.000461	0.0145	CcSEcCtD
Levocabastine—Nausea—Rosuvastatin—atherosclerosis	0.000459	0.0144	CcSEcCtD
Levocabastine—Asthenia—Simvastatin—atherosclerosis	0.00044	0.0138	CcSEcCtD
Levocabastine—Rash—Lovastatin—atherosclerosis	0.000413	0.013	CcSEcCtD
Levocabastine—Dermatitis—Lovastatin—atherosclerosis	0.000413	0.013	CcSEcCtD
Levocabastine—Headache—Lovastatin—atherosclerosis	0.000411	0.0129	CcSEcCtD
Levocabastine—Rash—Ezetimibe—atherosclerosis	0.000405	0.0127	CcSEcCtD
Levocabastine—Dermatitis—Ezetimibe—atherosclerosis	0.000405	0.0127	CcSEcCtD
Levocabastine—Asthenia—Niacin—atherosclerosis	0.000404	0.0127	CcSEcCtD
Levocabastine—Headache—Ezetimibe—atherosclerosis	0.000403	0.0126	CcSEcCtD
Levocabastine—Asthenia—Pravastatin—atherosclerosis	0.000398	0.0125	CcSEcCtD
Levocabastine—Nausea—Lovastatin—atherosclerosis	0.000389	0.0122	CcSEcCtD
Levocabastine—Rash—Simvastatin—atherosclerosis	0.000386	0.0121	CcSEcCtD
Levocabastine—Dermatitis—Simvastatin—atherosclerosis	0.000386	0.0121	CcSEcCtD
Levocabastine—Headache—Simvastatin—atherosclerosis	0.000384	0.0121	CcSEcCtD
Levocabastine—Nausea—Ezetimibe—atherosclerosis	0.000382	0.012	CcSEcCtD
Levocabastine—Nausea—Simvastatin—atherosclerosis	0.000364	0.0114	CcSEcCtD
Levocabastine—Rash—Niacin—atherosclerosis	0.000355	0.0111	CcSEcCtD
Levocabastine—Dermatitis—Niacin—atherosclerosis	0.000355	0.0111	CcSEcCtD
Levocabastine—Headache—Niacin—atherosclerosis	0.000353	0.0111	CcSEcCtD
Levocabastine—Rash—Pravastatin—atherosclerosis	0.000349	0.011	CcSEcCtD
Levocabastine—Dermatitis—Pravastatin—atherosclerosis	0.000349	0.011	CcSEcCtD
Levocabastine—Headache—Pravastatin—atherosclerosis	0.000347	0.0109	CcSEcCtD
Levocabastine—Nausea—Niacin—atherosclerosis	0.000334	0.0105	CcSEcCtD
Levocabastine—Nausea—Pravastatin—atherosclerosis	0.000329	0.0103	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CCR2—atherosclerosis	0.000323	0.00285	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—F2—atherosclerosis	0.000316	0.00279	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—GHRL—atherosclerosis	0.000315	0.00278	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—APOA4—atherosclerosis	0.000304	0.00269	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000303	0.00268	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—EDNRA—atherosclerosis	0.000293	0.00259	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CCR2—atherosclerosis	0.000293	0.00259	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000292	0.00258	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—GHRL—atherosclerosis	0.000286	0.00252	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CCL2—atherosclerosis	0.000281	0.00249	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCL4—atherosclerosis	0.00028	0.00248	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—KNG1—atherosclerosis	0.000276	0.00244	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000274	0.00243	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—APOA2—atherosclerosis	0.000262	0.00231	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—KNG1—atherosclerosis	0.000251	0.00222	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—UTS2—atherosclerosis	0.00025	0.00221	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—AGTR1—atherosclerosis	0.000249	0.0022	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—UTS2—atherosclerosis	0.000248	0.00219	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CX3CR1—atherosclerosis	0.00024	0.00212	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CASR—atherosclerosis	0.00024	0.00212	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—CASR—atherosclerosis	0.000238	0.0021	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CX3CL1—atherosclerosis	0.000235	0.00208	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—EDN1—atherosclerosis	0.000233	0.00206	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CCL5—atherosclerosis	0.000231	0.00204	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CNR2—atherosclerosis	0.000223	0.00197	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CXCL8—atherosclerosis	0.000223	0.00197	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—MMP3—atherosclerosis	0.000222	0.00196	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000222	0.00196	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—UTS2—atherosclerosis	0.000222	0.00196	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—PRKCG—atherosclerosis	0.00022	0.00194	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CASR—atherosclerosis	0.000213	0.00188	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—EDN1—atherosclerosis	0.000211	0.00187	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CCL5—atherosclerosis	0.00021	0.00185	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PRKCG—atherosclerosis	0.000199	0.00176	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—VWF—atherosclerosis	0.000198	0.00175	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—APOC3—atherosclerosis	0.000197	0.00174	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—LDLR—atherosclerosis	0.000196	0.00173	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—AGT—atherosclerosis	0.000193	0.00171	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCL3—atherosclerosis	0.000191	0.00169	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL4—atherosclerosis	0.000184	0.00163	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CX3CR1—atherosclerosis	0.000184	0.00162	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NCF1—atherosclerosis	0.000183	0.00162	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—F2—atherosclerosis	0.000178	0.00158	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—AGT—atherosclerosis	0.000175	0.00155	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCR2—atherosclerosis	0.000173	0.00153	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EDNRA—atherosclerosis	0.000173	0.00153	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CYBA—atherosclerosis	0.000172	0.00152	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—EDNRA—atherosclerosis	0.000172	0.00152	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000171	0.00151	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CNR2—atherosclerosis	0.000171	0.00151	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PLAT—atherosclerosis	0.000169	0.00149	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PARP1—atherosclerosis	0.000169	0.00149	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—GHRL—atherosclerosis	0.000169	0.00149	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—GHRL—atherosclerosis	0.000167	0.00148	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—UTS2—atherosclerosis	0.000164	0.00145	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—F2—atherosclerosis	0.000162	0.00143	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—NFKB1—atherosclerosis	0.000162	0.00143	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CX3CR1—atherosclerosis	0.000157	0.00139	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000155	0.00137	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CX3CL1—atherosclerosis	0.000154	0.00136	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—atherosclerosis	0.000154	0.00136	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—atherosclerosis	0.00015	0.00132	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—KNG1—atherosclerosis	0.000148	0.00131	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—AGTR1—atherosclerosis	0.000147	0.0013	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—KNG1—atherosclerosis	0.000147	0.0013	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR2—atherosclerosis	0.000146	0.00129	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—AGTR1—atherosclerosis	0.000146	0.00129	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—STAT3—atherosclerosis	0.000145	0.00128	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CCL2—atherosclerosis	0.000144	0.00128	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PLG—atherosclerosis	0.000143	0.00127	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCL4—atherosclerosis	0.00014	0.00124	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—MAPK3—atherosclerosis	0.000139	0.00123	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SOCS3—atherosclerosis	0.000136	0.0012	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—atherosclerosis	0.000133	0.00117	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—EDNRA—atherosclerosis	0.000133	0.00117	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—atherosclerosis	0.000131	0.00116	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MMP3—atherosclerosis	0.000131	0.00116	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IGF2—atherosclerosis	0.000131	0.00115	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—atherosclerosis	0.000131	0.00115	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—APOB—atherosclerosis	0.000127	0.00112	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.000126	0.00111	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000126	0.00111	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—UTS2—atherosclerosis	0.000125	0.0011	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EDN1—atherosclerosis	0.000125	0.0011	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCL5—atherosclerosis	0.000124	0.00109	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—EDN1—atherosclerosis	0.000124	0.00109	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—LPL—atherosclerosis	0.000121	0.00107	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CASR—atherosclerosis	0.00012	0.00106	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CX3CR1—atherosclerosis	0.00012	0.00106	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PRKCG—atherosclerosis	0.000118	0.00104	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CX3CL1—atherosclerosis	0.000118	0.00104	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—atherosclerosis	0.000116	0.00103	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SPP1—atherosclerosis	0.000115	0.00101	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CXCL8—atherosclerosis	0.000114	0.00101	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000114	0.00101	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000114	0.00101	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.000113	0.000998	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CNR2—atherosclerosis	0.000111	0.000984	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000111	0.00098	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—atherosclerosis	0.000111	0.000979	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PDGFB—atherosclerosis	0.000106	0.000938	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—AGT—atherosclerosis	0.000104	0.000915	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—AGT—atherosclerosis	0.000103	0.000908	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—APOE—atherosclerosis	0.000102	0.000897	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—LEP—atherosclerosis	0.000102	0.000897	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CAV1—atherosclerosis	0.000101	0.000889	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—APOA1—atherosclerosis	0.0001	0.000887	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	9.73e-05	0.00086	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—ESR1—atherosclerosis	9.69e-05	0.000856	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	9.67e-05	0.000855	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCL3—atherosclerosis	9.58e-05	0.000846	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—F2—atherosclerosis	9.57e-05	0.000846	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—F2—atherosclerosis	9.5e-05	0.000839	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—AKT1—atherosclerosis	9.37e-05	0.000828	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	9.19e-05	0.000812	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CG—atherosclerosis	9.16e-05	0.000809	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—MAPK3—atherosclerosis	8.77e-05	0.000775	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—INS—atherosclerosis	8.67e-05	0.000766	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—EDNRA—atherosclerosis	8.66e-05	0.000765	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCR2—atherosclerosis	8.66e-05	0.000765	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCL2—atherosclerosis	8.53e-05	0.000754	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	8.49e-05	0.000751	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—GHRL—atherosclerosis	8.44e-05	0.000746	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IGF1—atherosclerosis	8.39e-05	0.000741	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	8.2e-05	0.000725	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	8.14e-05	0.000719	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SERPINE1—atherosclerosis	7.97e-05	0.000704	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NOS3—atherosclerosis	7.61e-05	0.000672	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—KNG1—atherosclerosis	7.41e-05	0.000655	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—AGTR1—atherosclerosis	7.37e-05	0.000651	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL4—atherosclerosis	7.2e-05	0.000636	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—UTS2—atherosclerosis	7.06e-05	0.000624	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	6.81e-05	0.000601	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CASR—atherosclerosis	6.77e-05	0.000598	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCL8—atherosclerosis	6.75e-05	0.000596	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—AKT1—atherosclerosis	6.52e-05	0.000576	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL6—atherosclerosis	6.41e-05	0.000567	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—UTS2—atherosclerosis	6.41e-05	0.000567	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CNR2—atherosclerosis	6.3e-05	0.000556	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	6.29e-05	0.000556	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—EDN1—atherosclerosis	6.25e-05	0.000552	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCL5—atherosclerosis	6.2e-05	0.000548	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CX3CR1—atherosclerosis	6.15e-05	0.000543	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CASR—atherosclerosis	6.15e-05	0.000543	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MMP9—atherosclerosis	6.1e-05	0.000539	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NFKB1—atherosclerosis	6.04e-05	0.000533	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CX3CL1—atherosclerosis	6.03e-05	0.000533	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MAPK8—atherosclerosis	5.93e-05	0.000524	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—AKT1—atherosclerosis	5.92e-05	0.000523	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CNR2—atherosclerosis	5.72e-05	0.000505	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	5.61e-05	0.000495	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—VEGFA—atherosclerosis	5.48e-05	0.000484	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—STAT3—atherosclerosis	5.43e-05	0.000479	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—AGT—atherosclerosis	5.18e-05	0.000458	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MAPK3—atherosclerosis	5.18e-05	0.000458	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TGFB1—atherosclerosis	5.03e-05	0.000444	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL3—atherosclerosis	4.92e-05	0.000434	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCR2—atherosclerosis	4.9e-05	0.000433	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—EDNRA—atherosclerosis	4.9e-05	0.000433	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—F2—atherosclerosis	4.79e-05	0.000423	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—GHRL—atherosclerosis	4.77e-05	0.000422	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—APOA4—atherosclerosis	4.61e-05	0.000408	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	4.6e-05	0.000406	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—EDNRA—atherosclerosis	4.45e-05	0.000393	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCR2—atherosclerosis	4.45e-05	0.000393	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	4.43e-05	0.000392	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—GHRL—atherosclerosis	4.33e-05	0.000383	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCL2—atherosclerosis	4.27e-05	0.000377	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL4—atherosclerosis	4.25e-05	0.000376	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—KNG1—atherosclerosis	4.19e-05	0.00037	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—AGTR1—atherosclerosis	4.16e-05	0.000368	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—APOA2—atherosclerosis	3.97e-05	0.000351	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—KNG1—atherosclerosis	3.8e-05	0.000336	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL6—atherosclerosis	3.79e-05	0.000335	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—UTS2—atherosclerosis	3.79e-05	0.000335	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—AGTR1—atherosclerosis	3.78e-05	0.000334	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CX3CR1—atherosclerosis	3.63e-05	0.000321	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CASR—atherosclerosis	3.63e-05	0.000321	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CX3CL1—atherosclerosis	3.56e-05	0.000315	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—EDN1—atherosclerosis	3.53e-05	0.000312	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCL5—atherosclerosis	3.5e-05	0.000309	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—AKT1—atherosclerosis	3.5e-05	0.000309	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CNR2—atherosclerosis	3.38e-05	0.000298	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCL8—atherosclerosis	3.38e-05	0.000298	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—MMP3—atherosclerosis	3.37e-05	0.000298	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	3.36e-05	0.000297	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PRKCG—atherosclerosis	3.33e-05	0.000294	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—EDN1—atherosclerosis	3.2e-05	0.000283	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL5—atherosclerosis	3.18e-05	0.000281	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PRKCG—atherosclerosis	3.02e-05	0.000267	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—VWF—atherosclerosis	3.01e-05	0.000266	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—APOC3—atherosclerosis	2.99e-05	0.000264	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LDLR—atherosclerosis	2.97e-05	0.000263	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—AGT—atherosclerosis	2.93e-05	0.000259	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL3—atherosclerosis	2.9e-05	0.000257	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NCF1—atherosclerosis	2.78e-05	0.000246	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—F2—atherosclerosis	2.71e-05	0.000239	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—AGT—atherosclerosis	2.66e-05	0.000235	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EDNRA—atherosclerosis	2.63e-05	0.000232	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCR2—atherosclerosis	2.63e-05	0.000232	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CYBA—atherosclerosis	2.61e-05	0.000231	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CG—atherosclerosis	2.59e-05	0.000229	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PLAT—atherosclerosis	2.56e-05	0.000226	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PARP1—atherosclerosis	2.56e-05	0.000226	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GHRL—atherosclerosis	2.56e-05	0.000226	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—F2—atherosclerosis	2.46e-05	0.000217	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CG—atherosclerosis	2.35e-05	0.000208	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KNG1—atherosclerosis	2.25e-05	0.000199	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—AGTR1—atherosclerosis	2.23e-05	0.000197	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL2—atherosclerosis	2.19e-05	0.000194	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PLG—atherosclerosis	2.18e-05	0.000192	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SOCS3—atherosclerosis	2.06e-05	0.000182	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MMP3—atherosclerosis	1.99e-05	0.000176	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IGF2—atherosclerosis	1.98e-05	0.000175	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—APOB—atherosclerosis	1.92e-05	0.00017	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCL8—atherosclerosis	1.91e-05	0.000169	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EDN1—atherosclerosis	1.89e-05	0.000167	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL5—atherosclerosis	1.88e-05	0.000166	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LPL—atherosclerosis	1.84e-05	0.000162	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PRKCG—atherosclerosis	1.79e-05	0.000158	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SPP1—atherosclerosis	1.74e-05	0.000154	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCL8—atherosclerosis	1.73e-05	0.000153	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PDGFB—atherosclerosis	1.61e-05	0.000142	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—AGT—atherosclerosis	1.57e-05	0.000139	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LEP—atherosclerosis	1.54e-05	0.000136	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—APOE—atherosclerosis	1.54e-05	0.000136	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CAV1—atherosclerosis	1.53e-05	0.000135	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—APOA1—atherosclerosis	1.52e-05	0.000134	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ESR1—atherosclerosis	1.47e-05	0.00013	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—F2—atherosclerosis	1.45e-05	0.000128	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	1.39e-05	0.000123	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	1.33e-05	0.000118	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—INS—atherosclerosis	1.32e-05	0.000116	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL2—atherosclerosis	1.29e-05	0.000114	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IGF1—atherosclerosis	1.27e-05	0.000112	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	1.21e-05	0.000107	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NOS3—atherosclerosis	1.15e-05	0.000102	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	1.02e-05	9.04e-05	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	9.88e-06	8.73e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL6—atherosclerosis	9.73e-06	8.6e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MMP9—atherosclerosis	9.26e-06	8.18e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	9.16e-06	8.09e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	9e-06	7.95e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	8.98e-06	7.93e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	8.31e-06	7.34e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—STAT3—atherosclerosis	8.23e-06	7.27e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	7.86e-06	6.95e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	7.63e-06	6.74e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL6—atherosclerosis	5.75e-06	5.08e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—AKT1—atherosclerosis	5.3e-06	4.69e-05	CbGpPWpGaD
